KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Current Deferred Revenue: 2014-2024

Historic Current Deferred Revenue for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Dec 2024 value amounting to $11.0 million.

  • Aurinia Pharmaceuticals' Current Deferred Revenue rose 6.92% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 6.92%. This contributed to the annual value of $11.0 million for FY2024, which is 128.59% up from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Current Deferred Revenue stood at $11.0 million for FY2024, which was up 128.59% from $4.8 million recorded in FY2023.
  • In the past 5 years, Aurinia Pharmaceuticals' Current Deferred Revenue ranged from a high of $11.0 million in FY2024 and a low of $190,000 during FY2021.
  • In the last 3 years, Aurinia Pharmaceuticals' Current Deferred Revenue had a median value of $4.8 million in 2023 and averaged $6.3 million.
  • Data for Aurinia Pharmaceuticals' Current Deferred Revenue shows a peak YoY spiked of 1,556.84% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Aurinia Pharmaceuticals' Current Deferred Revenue stood at $190,000 in 2021, then skyrocketed by 1,556.84% to $3.1 million in 2022, then soared by 52.89% to $4.8 million in 2023, then spiked by 128.59% to $11.0 million in 2024.